On April 24, Mickey Matsumoto, Ph.D., CSO of Arialys, gave an oral presentation entitled, "Monoclonal Humanized One-Armed Antibody Blocking Therapy for Anti-NMDAR Encephalitis."

Click here to view the abstract.